Open AccessThis article is
- freely available
Cancer Stem Cells in Head and Neck Cancer
Department of Pathology, University of Colorado Denver, AMC 12800 E. 19th Ave., Aurora, CO 80045, USA
Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO 80045, USA
* Author to whom correspondence should be addressed.
Received: 2 December 2010; in revised form: 24 December 2010 / Accepted: 14 January 2011 / Published: 20 January 2011
Abstract: Head and neck cancer (HNC) is the sixth most common malignancy world-wide, however the survival rate has not improved for the past 20 years. In recent years, the cancer stem cell (CSC) hypothesis has gained ground in several malignancies and there is mounting evidence suggesting CSCs mediate tumor resistance to chemotherapy and radiation therapy. However, the CSC theory is also challenged at least in certain types of cancer. Here we review the progress of CSC studies in HNC, which suggest that HNC conforms to the CSC model. The identified CSC markers and their tumor initiation properties provide a framework for the development of novel therapeutic strategies for HNC.
Keywords: chemoresistance; radioresistance; transplantation; tumorigenicity
Citations to this Article
Cite This Article
MDPI and ACS Style
Mitra, D.; Malkoski, S.P.; Wang, X.-J. Cancer Stem Cells in Head and Neck Cancer. Cancers 2011, 3, 415-427.
Mitra D, Malkoski SP, Wang X-J. Cancer Stem Cells in Head and Neck Cancer. Cancers. 2011; 3(1):415-427.
Mitra, Doyel; Malkoski, Stephen P.; Wang, Xiao-Jing. 2011. "Cancer Stem Cells in Head and Neck Cancer." Cancers 3, no. 1: 415-427.